Press Release | 04/05/2019

Wuhan Enters Mushroom Psychedelic Medicine Market

BARCELONA, Spain, April 05, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Wuhan General Group (China), Inc. (OTC PINK: WUHN) (the “Company” and “Wuhan”), announced today that its subsidiary MJ MedTech, Inc. (MJ MedTech) has created a new division dedicated to exploring opportunities in the psychedelic medicine space….

Read More


Press Release | 03/29/2019

Wuhan Updates on Hemp and CBD-Based Products Line

BARCELONA, Spain, March 28, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE —  Wuhan General Group (China), Inc. (OTC: WUHN) (the “Company” and “Wuhan”), announced today that its subsidiary MJ MedTech, Inc. (MJ MedTech) has commenced formulations and prototyping for the Dr. AnnaRx line of hemp and CBD based products…

Read More


Press Release | 01/30/2019

Wuhan WUHAN AND BIODELTA FORM INTERNATIONAL JOINT VENTURE

LOS ANGELES, Jan. 30, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Wuhan General Group (China), Inc. (USOTC: WUHN) (the “Company” and “Wuhan”), announced today that its wholly-owned subsidiary MJ MedTech, Inc. (MJ MedTech) and Biodelta Nutraceuticals, Ltd. (Biodelta) have entered into a joint venture to develop, brand, market and commercialize the internationally trademarked Dr. AnnaRx….

Read More


Press Release | 01/22/2019

WUHAN GENERAL GROUP ACQUIRES MJ MEDTECH

MONTREAL, Jan. 22, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Wuhan General Group (China), Inc. (OTC PINK: WUHN) (the “Company” and “Wuhan”), announces today that the Company has successfully completed the acquisition of MJ MedTech, a nutraceutical biotechnology company that owns, develops and commercializes a range of CBD-based products under the International trademarked brand Dr. AnnaRx…

Read More


Press Release | 12/19/2018

Wuhan Provides Update on Its Entry into The Cannabis Market

MONTREAL, Dec. 19, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE — Wuhan General Group (China), Inc. (OTC PINK: WUHN) (the “Company” and “Wuhan”), announces today that the Company is successfully gaining a strong foothold in Canada, Europe, US and Australia through Cannabis regulatory compliance, either by obtaining or having access to the needed permits to cultivate, transform and sell cannabis products in the permitted location…

Read More


Press Release |
11/19/2018

Wuhan Provides MJ MedTech Acquisition Update

TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE —  Wuhan General Group (China), Inc. (OTC PINK: WUHN) (the “Company” and “Wuhan”), today announces that it has agreed in principle to the terms and conditions regarding the previously announced acquisition of MJ MedTech, which will be concluded by December 15, 2018. Full details of the acquisition will be made public in the coming weeks…

Read More


Press Release | 10/09/2018

Medical Marijuana Company Acquisition: Wuhan Strengthens International Entry in the Marijuana Market

TORONTO, Oct. 09, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE — Wuhan General Group (China), Inc. (OTC Pink: WUHN) (“Wuhan”), is excited to announce further information on the proposed acquisition of MJ MedTech Inc. (“MJ MedTech”). The Medical Cannabis company is in a very strong position to capture a significant valuation going forward within the massive Medical Marijuana and Cannabidiol (CBD) Market…

Read More


Press Release | 10/04/2018

ePlay and Wuhan Announce Strategic Partnership to Create New Medical Cannabis App

CALGARY, Alberta, Oct. 04, 2018 (GLOBE NEWSWIRE) — ePlay Digital Inc. (CSE:EPY) is delighted to announce a new exclusive strategic partnership agreement signed today with Wuhan General Group (China), Inc. (OTC:WUHN) to utilize Mobvovivo’s Augmented Reality (AR) platform in education, mobile product information, and e-commerce…

Read More


Press Release | 10/04/2018

Wuhan Signs Letter of Intent to Acquire MJ MedTech

TORONTO, Oct. 04, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE — Wuhan General Group (China), Inc. (OTC PINK: WUHN) (“Wuhan” or the “Company”), announced today that it has signed a non-binding Letter of Intent (“LOI”) to acquire all of the issued and outstanding shares in MJ MedTech Inc. (“MJ MedTech”). …

Read More